Maven Securities LTD Sage Therapeutics, Inc. Transaction History

Maven Securities LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $415,551 - $600,383	-7,572 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $534,961 - $732,666	7,572 New	7,572 $577,000
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $1.64 Million - $4.84 Million	-62,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $3.77 Million - $9.7 Million	62,700 New	62,700 $4.55 Million
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $125,450 - $213,896	-1,531 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $211,446 - $258,800	1,531 New	1,531 $213,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $333M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.